409 related articles for article (PubMed ID: 27363826)
1. Endocrine-disrupting chemicals and skin manifestations.
Ju Q; Zouboulis CC
Rev Endocr Metab Disord; 2016 Sep; 17(3):449-457. PubMed ID: 27363826
[TBL] [Abstract][Full Text] [Related]
2. Human exposure to synthetic endocrine disrupting chemicals (S-EDCs) is generally negligible as compared to natural compounds with higher or comparable endocrine activity. How to evaluate the risk of the S-EDCs?
Autrup H; Barile FA; Berry SC; Blaauboer BJ; Boobis A; Bolt H; Borgert CJ; Dekant W; Dietrich D; Domingo JL; Gori GB; Greim H; Hengstler J; Kacew S; Marquardt H; Pelkonen O; Savolainen K; Heslop-Harrison P; Vermeulen NP
Toxicol In Vitro; 2020 Sep; 67():104861. PubMed ID: 32360643
[TBL] [Abstract][Full Text] [Related]
3. Human exposure to synthetic endocrine disrupting chemicals (S-EDCs) is generally negligible as compared to natural compounds with higher or comparable endocrine activity. How to evaluate the risk of the S-EDCs?
Autrup H; Barile FA; Berry SC; Blaauboer BJ; Boobis A; Bolt H; Borgert CJ; Dekant W; Dietrich D; Domingo JL; Gori GB; Greim H; Hengstler J; Kacew S; Marquardt H; Pelkonen O; Savolainen K; Heslop-Harrison P; Vermeulen NP
Environ Toxicol Pharmacol; 2020 Aug; 78():103396. PubMed ID: 32391796
[TBL] [Abstract][Full Text] [Related]
4. Human exposure to synthetic endocrine disrupting chemicals (S-EDCs) is generally negligible as compared to natural compounds with higher or comparable endocrine activity. How to evaluate the risk of the S-EDCs?
Autrup H; Barile FA; Berry SC; Blaauboer BJ; Boobis A; Bolt H; Borgert CJ; Dekant W; Dietrich D; Domingo JL; Gori GB; Greim H; Hengstler J; Kacew S; Marquardt H; Pelkonen O; Savolainen K; Heslop-Harrison P; Vermeulen NP
J Toxicol Environ Health A; 2020 Jul; 83(13-14):485-494. PubMed ID: 32552445
[TBL] [Abstract][Full Text] [Related]
5. Gene-environment interactions in male reproductive health: special reference to the aryl hydrocarbon receptor signaling pathway.
Brokken LJ; Giwercman YL
Asian J Androl; 2014; 16(1):89-96. PubMed ID: 24369137
[TBL] [Abstract][Full Text] [Related]
6. Human exposure to endocrine disrupting chemicals: effects on the male and female reproductive systems.
Sifakis S; Androutsopoulos VP; Tsatsakis AM; Spandidos DA
Environ Toxicol Pharmacol; 2017 Apr; 51():56-70. PubMed ID: 28292651
[TBL] [Abstract][Full Text] [Related]
7. Human exposure to synthetic endocrine disrupting chemicals (S-EDCs) is generally negligible as compared to natural compounds with higher or comparable endocrine activity. How to evaluate the risk of the S-EDCs?
Autrup H; Barile FA; Berry SC; Blaauboer BJ; Boobis A; Bolt H; Borgert CJ; Dekant W; Dietrich D; Domingo JL; Gori GB; Greim H; Hengstler J; Kacew S; Marquardt H; Pelkonen O; Savolainen K; Heslop-Harrison P; Vermeulen NP
Chem Biol Interact; 2020 Aug; 326():109099. PubMed ID: 32370863
[TBL] [Abstract][Full Text] [Related]
8. Persistent environmental endocrine-disrupting chemicals in ovarian follicular fluid and
Björvang RD; Damdimopoulou P
Ups J Med Sci; 2020 May; 125(2):85-94. PubMed ID: 32093529
[TBL] [Abstract][Full Text] [Related]
9. Endocrine disruptors targeting ERbeta function.
Swedenborg E; Pongratz I; Gustafsson JA
Int J Androl; 2010 Apr; 33(2):288-97. PubMed ID: 20050941
[TBL] [Abstract][Full Text] [Related]
10. Effects of Environmental Endocrine-Disrupting Chemicals on Female Reproductive Health.
Liu Q
Adv Exp Med Biol; 2021; 1300():205-229. PubMed ID: 33523436
[TBL] [Abstract][Full Text] [Related]
11. Endocrine disrupting chemicals: exposure, effects on human health, mechanism of action, models for testing and strategies for prevention.
Yilmaz B; Terekeci H; Sandal S; Kelestimur F
Rev Endocr Metab Disord; 2020 Mar; 21(1):127-147. PubMed ID: 31792807
[TBL] [Abstract][Full Text] [Related]
12. Human exposure to synthetic endocrine disrupting chemicals (S-EDCs) is generally negligible as compared to natural compounds with higher or comparable endocrine activity. How to evaluate the risk of the S-EDCs?
Autrup H; Barile FA; Berry SC; Blaauboer BJ; Boobis A; Bolt H; Hengstler J; Borgert CJ; Dekant W; Dietrich D; Domingo JL; Gori GB; Greim H; Kacew S; Marquardt H; Pelkonen O; Savolainen K; Heslop-Harrison P; Vermeulen NP
Food Chem Toxicol; 2020 Aug; 142():111349. PubMed ID: 32360905
[TBL] [Abstract][Full Text] [Related]
13. The effect of endocrine-disrupting chemicals on placental development.
Yan Y; Guo F; Liu K; Ding R; Wang Y
Front Endocrinol (Lausanne); 2023; 14():1059854. PubMed ID: 36896182
[TBL] [Abstract][Full Text] [Related]
14. Neuroendocrine and behavioral effects of embryonic exposure to endocrine disrupting chemicals in birds.
Ottinger MA; Lavoie E; Thompson N; Barton A; Whitehouse K; Barton M; Abdelnabi M; Quinn M; Panzica G; Viglietti-Panzica C
Brain Res Rev; 2008 Mar; 57(2):376-85. PubMed ID: 18006066
[TBL] [Abstract][Full Text] [Related]
15. Cultured human peripheral blood mononuclear cells alter their gene expression when challenged with endocrine-disrupting chemicals.
Wens B; De Boever P; Verbeke M; Hollanders K; Schoeters G
Toxicology; 2013 Jan; 303():17-24. PubMed ID: 23146750
[TBL] [Abstract][Full Text] [Related]
16. Endocrine disrupting chemicals and bone.
Turan S
Best Pract Res Clin Endocrinol Metab; 2021 Sep; 35(5):101495. PubMed ID: 33618984
[TBL] [Abstract][Full Text] [Related]
17. Cloning of circadian rhythmic pathway genes and perturbation of oscillation patterns in endocrine disrupting chemicals (EDCs)-exposed mangrove killifish Kryptolebias marmoratus.
Rhee JS; Kim BM; Lee BY; Hwang UK; Lee YS; Lee JS
Comp Biochem Physiol C Toxicol Pharmacol; 2014 Aug; 164():11-20. PubMed ID: 24726801
[TBL] [Abstract][Full Text] [Related]
18. Assessing effects of environmental chemicals on neuroendocrine systems: potential mechanisms and functional outcomes.
Ottinger MA; Carro T; Bohannon M; Baltos L; Marcell AM; McKernan M; Dean KM; Lavoie E; Abdelnabi M
Gen Comp Endocrinol; 2013 Sep; 190():194-202. PubMed ID: 23773971
[TBL] [Abstract][Full Text] [Related]
19. Molecular mechanism(s) of endocrine-disrupting chemicals and their potent oestrogenicity in diverse cells and tissues that express oestrogen receptors.
Lee HR; Jeung EB; Cho MH; Kim TH; Leung PC; Choi KC
J Cell Mol Med; 2013 Jan; 17(1):1-11. PubMed ID: 23279634
[TBL] [Abstract][Full Text] [Related]
20. Endocrine disrupting chemicals as potential risk factor for estrogen-dependent cancers.
Rutkowska AZ; Szybiak A; Serkies K; Rachoń D
Pol Arch Med Wewn; 2016 Aug; 126(7-8):562-70. PubMed ID: 27509913
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
